Chad Cowan

Chief Scientific Officer, Century Therapeutics (United States).

Companies

Century Therapeutics (United States)Chief Scientific Officer Oct 3, 2024 to now¹

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Century Therapeutics (United States) IPSC1,186,019 shares²$1.7M at $1.48Jun 15, 2026

As of each latest filing. The line shows shares held over time.

Jun 11, 2026Shares withheld for tax 358 shares at $2.24 of Century Therapeutics (United States)²
Apr 1, 2026Shares withheld for tax 1,365 shares at $2.19 of Century Therapeutics (United States)³
Mar 11, 2026Shares withheld for tax 1,431 shares at $2.73 of Century Therapeutics (United States)⁴
Feb 2, 2026Granted 135,000 shares of Century Therapeutics (United States)⁵
Jan 2, 2026Shares withheld for tax 1,611 shares at $1.00 of Century Therapeutics (United States)⁶
Dec 22, 2025Bought 58,060 shares at $0.85 of Century Therapeutics (United States)⁷
Nov 20, 2025Sold 5,462 shares at $0.50 of Century Therapeutics (United States)⁸
Sep 18, 2025Granted 762,543 shares of Century Therapeutics (United States)⁹
Mar 11, 2025Granted 19,500 shares of Century Therapeutics (United States)¹⁰
Oct 1, 2024Granted 74,376 shares of Century Therapeutics (United States)¹¹

The numbers on this page point here. Each one links to the record it came from.